Alpha-Galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens

Mucosal delivery of vaccines against sexually transmitted pathogens is important to elicit strong immune responses at biologically relevant sites. However, inclusion of appropriate adjuvants is essential to overcome the inherent mucosal tolerance. We present evidence in support of the effectiveness...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Vaccine
Päätekijät: Courtney, Amy N., Nehete, Pramod N., Nehete, Bharti P., Thapa, Prakash, Zhou, Dapeng, Sastry, K. Jagannadha
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5798449/
https://ncbi.nlm.nih.gov/pubmed/19200849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.01.083
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia